Shared decision‐making for supporting women’s decisions about breast cancer screening

Background In breast cancer screening programmes, women may have discussions with a healthcare provider to help them decide whether or not they wish to join the breast cancer screening programme. This process is called shared decision‐making (SDM) and involves discussions and decisions based on the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2024-05, Vol.2024 (5), p.CD013822
Hauptverfasser: Franco, Juan VA, Riganti, Paula, Ruiz Yanzi, M. Victoria, Escobar Liquitay, Camila Micaela, Sgarbossa, Nadia J, Alarcon-Ruiz, Christoper A., Kopitowski, Karin S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In breast cancer screening programmes, women may have discussions with a healthcare provider to help them decide whether or not they wish to join the breast cancer screening programme. This process is called shared decision‐making (SDM) and involves discussions and decisions based on the evidence and the person's values and preferences. SDM is becoming a recommended approach in clinical guidelines, extending beyond decision aids. However, the overall effect of SDM in women deciding to participate in breast cancer screening remains uncertain. Objectives To assess the effect of SDM on women's satisfaction, confidence, and knowledge when deciding whether to participate in breast cancer screening. Search methods We searched the Cochrane Breast Cancer Group's Specialised Register, CENTRAL, MEDLINE, Embase, CINAHL, PsycINFO, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform on 8 August 2023. We also screened s from two relevant conferences from 2020 to 2023. Selection criteria We included parallel randomised controlled trials (RCTs) and cluster‐RCTs assessing interventions targeting various components of SDM. The focus was on supporting women aged 40 to 75 at average or above‐average risk of breast cancer in their decision to participate in breast cancer screening. Data collection and analysis Two review authors independently assessed studies for inclusion and conducted data extraction, risk of bias assessment, and GRADE assessment of the certainty of the evidence. Review outcomes included satisfaction with the decision‐making process, confidence in the decision made, knowledge of all options, adherence to the chosen option, women's involvement in SDM, woman‐clinician communication, and mental health. Main results We identified 19 studies with 64,215 randomised women, mostly with an average to moderate risk of breast cancer. Two studies covered all aspects of SDM; six examined shortened forms of SDM involving communication on risks and personal values; and 11 focused on enhanced communication of risk without other SDM aspects. SDM involving all components compared to control The two eligible studies did not assess satisfaction with the SDM process or confidence in the decision. Based on a single study, SDM showed uncertain effects on participant knowledge regarding the age to start screening (risk ratio (RR) 1.18, 95% confidence interval (CI) 0.61 to 2.28; 133 women; very low certainty evidence) and
ISSN:1465-1858
1469-493X
1465-1858
1469-493X
DOI:10.1002/14651858.CD013822.pub2